You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. FULGENT GENETICS INC

Fulgent Genetics Inc XNAS: FLGT

Fulgent Genetics Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
Download real time

17.92 0.06 (0.34%)

28.63% Fall from 52W High

213.9K XNAS Volume

XNAS 21 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Fulgent Genetics Inc is on 02 May 2025 for the purpose of Fulgent Genetics Inc First Quarter Earnings Result for 2025 See details

Fulgent Genetics Inc Key Metrics

Default

Market Capitalization

Below industry Median
553.1

PE TTM

Negative PE TTM
-13

PEG TTM

Negative PEG TTM
-0.2

Price to Book

Low in industry
0.5

Institutional holding current Qtr %

Below industry Median
54.4

Revenue Growth Qtr YoY %

Below industry Median
8.1

Operating Revenue growth TTM %

Negative Operating Revenue growth TTM %
-2

Net Profit Qtr Growth YoY %

Below industry Median
95.4

Net Profit TTM Growth %

Below industry Median
74.6

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-21.2

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-26.1

Piotroski Score

Below industry Median
3

Rel Perf vs Sector quarter%

16.3

ROE Annual %

Negative ROE Annual %
-3.8

RoA Annual %

Negative RoA Annual %
-3.5
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
19.3 / 100
Momentum Score
Technically Neutral
50.0 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
20
1Yr Price target upside is 12%
3 analysts

12

S

8

W

2

O

2

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Fulgent Genetics Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '26200400600800Actual RevenueAvg. Estimate
Hit

Fulgent Genetics Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-1.4
Avg. Estimate
-2
Low Estimate
-2
High Estimate
-2
Current EPS
Avg. Estimate
Miss

EPS is expected to reduce by 44.0% in FY25

Consensus Recommendation

3 ANALYST Recommendations
HOLD

Created with Highcharts 7.2.22Hold1Buy

The consensus recommendation from 3 analysts for Fulgent Genetics Inc is HOLD

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Fulgent Genetics Inc Stock Analysis

Fulgent Genetics Inc stock analysis with key metrics, changes, and trends.

Fulgent Genetics Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$283.47 M1.99%negative

Annual Revenue fell 1.99%, in the last year to $283.47 M. Its sector's average revenue growth for the last fiscal year was 8.5%.

Annual Net Profit$42.71 M74.55%positive

Annual Net Profit rose 74.55% in the last year to $42.71 M. Its sector's average net profit growth for the last fiscal year was 13.48%.

Price to Earning Ratio-12.95-negative

Price to Earning Ratio is -12.95, which is negative.

Stock Price$17.92-11.98%negative

Stock Price fell 11.98% and underperformed its sector by 11.86% in the past year.

Quarterly Revenue$76.21 M8.1%positive

Quarterly Revenue rose 8.1% YoY to $76.21 M. Its sector's average revenue growth YoY for the quarter was 10.69%.

Quarterly Net profit$5.89 M95.41%positive

Quarterly Net profit rose 95.41% YoY to $5.89 M. Its sector's average net profit growth YoY for the quarter was 56.91%.

Debt to Equity Ratio0.01-positive

Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-3.76 %-3.76%negative

Return on Equity(ROE) for the last financial year was -3.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding28.67 %-7.35%negative

Mutual Fund Holding decreased by 7.35% in the last quarter to 28.67.

Promoter Share Holding13.63 %1.85%positive

Promoter Share Holding increased by 1.85% in the most recent quarter to 13.63%.

Institutional Holding54.40 %0.08%positive

Institutional Holding increased by 0.08% in the last quarter to 54.4.

VIEW LESS


Loading data..

Fulgent Genetics Inc - Company Profile

What does Fulgent Genetics Inc do?

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Fulgent Genetics Inc Management structure

All Gross Remunerations are in USD
Mr. Ming Hsieh
Chairman of the Board and Chief Executive Officer
6.13 M
2024
Gross Remuneration
Year
Mr. Jian Xie
President and Chief Operating Officer
2.38 M
2024
Gross Remuneration
Year
Mr. Paul Kim
Chief Financial Officer and Principal Accounting Officer
2.35 M
2024
Gross Remuneration
Year
Dr. Hanlin Gao, M.D.,PhD
Chief Scientific Officer and Laboratory Director
1.98 M
2024
Gross Remuneration
Year

Fulgent Genetics Inc Board of directors

All Gross Remunerations are in USD
Ms. Regina E. Groves
Independent Director
273 K
2024
Gross Remuneration
Year
Ms. Linda Marsh
Independent Director
270.5 K
2024
Gross Remuneration
Year
Dr. Michael Nohaile, PhD
Independent Director
268.5 K
2024
Gross Remuneration
Year
Mr. Ming Hsieh
Chairman of the Board and Chief Executive Officer
-
2024
Gross Remuneration
Year

Fulgent Genetics Inc FAQ

How is Fulgent Genetics Inc today?
Fulgent Genetics Inc today is trading in the green, and is up by 0.34% at 17.92.
Fulgent Genetics Inc is currently trading up 0.34% on an intraday basis. In the past week the stock fell -5.68%. stock has been up 4.80% in the past quarter and fell -11.98% in the past year. You can view this in the overview section.